Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Brain Behav Immun. 2008 Apr 18;22(6):994–1003. doi: 10.1016/j.bbi.2008.02.005

Table 4.

Regression analyses of age, neuroendocrine values and PTSD symptoms in predicting the % CD4+CD45RA+, % CD8+CD45RA+ and % CD45RO+ subsets

% CD4+CD45RA+ CD8+CD45RA+ CD45RO+
Model Ba SE B β t Bb SE B β t Bc SE B β t
Step 1 Age -.505 .234 -.377 -2.156* -.183 .132 -.253 -1.384 .236 .255 .167 .926
Step 2 Age -.449 .232 -.335 -1.933+ -.150 .132 -.207 -1.133 .226 .266 .159 .849
Norepinephrine -.192 .122 -.269 -1.575 -.094 .069 -.244 -1.358 -.142 .175 -.150 -.812
Cortisol -.060 .056 -.184 -1.061 -.037 .032 -.213 -1.166 .024 .071 .064 .340
Step 3 Age -.410 .196 -.306 -2.088* -.101 .125 -.139 -.807 .256 .252 .181 1.016
Norepinephrine -.157 .108 -.219 -1.450 -.153 .069 -.397 -2.231* -.175 .167 -.185 -1.049
Cortisol -.006 .049 -.019 -.126 -.027 .031 -.153 -.857 -.031 .068 -.082 -.454
SCL-90-R Depreesion 2.148 1.861 .246 1.154 2.068 1.186 .438 1.743 -.283 2.486 -.028 -.114
Intrusion (IES) .622 .190 .743 3.282** -.063 .121 -.139 -.520 -.688 .258 -.705 -2.664*
Avoidance (IES) -.346 .185 -.489 -1.864 .067 .118 .174 .564 .259 .233 .331 1.114
a

Note: For step 1, % CD4+CD45RA+ equation adjusted R2 = .122, ΔR2 = .142, p < .05; for step 2, % CD4+CD45RA+ equation adjusted R2 = .157, ΔR2 = .102, p >.05; for step 3, % CD4+CD45RA+ equation adjusted R2 = .435, ΔR2 = .308, p > .01.

b

For step 1, % CD8+CD45RA+ equation adjusted R2 = .031, ΔR2 = .064, p > .05; for step 2, % CD8+CD45RA+ equation adjusted R2 = .067, ΔR2 = .100, p > .05; for step 3, % CD8+CD45RA+ equation adjusted R2 = .215, ΔR2 = .214, p = .074.

c

For step 1, % CD45RO+ equation adjusted R2 = -.005, ΔR2 = .0028, p > .05; for step 2, % CD45RO+ equation adjusted R2 = .045, ΔR2 = .029, p > .05; for step 3, % CD45RO+ equation adjusted R2 = .131, ΔR2 = .243, p =.056.